During the past decade, Medtronic Italia S.p.A. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medtronic Italia S.p.A." are "Atrial Fibrillation" (1 trials), "Heart Failure, Congestive" (1 trials) and "Syncope" (1 trials). Many other conditions were trialed in "Medtronic Italia S.p.A." in a lesser frequency.

Most popular intervention types in "Medtronic Italia S.p.A." are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Dual chamber pacemeker" (1 trials) and "Pacemaker Medtronic EnRhythm" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medtronic Italia S.p.A." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Medtronic Italia S.p.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Medtronic Italia S.p.A., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Medtronic Italia S.p.A., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".